- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06464484
The Effects Of Probiotics On Stress Among Healthy Adults From Umm Al-Qura University At Makkah
The Effects Of Probiotics On Stress And Bowel Habits Among Healthy Adults From Umm Al-Qura University at Makkah: A Randomized Interventional Study
The goal of this clinical trial is to study the effects of probiotic supplementation on stress levels and bowel habits in healthy Saudi adults for both males and females.
The main questions it aims to answer are:
Does probiotic supplementation decrease stress levels? Does probiotic supplementation improve bowel habits?
Researchers compared between the intervention group receiving probiotic supplements with high stress levels with a control group not receiving probiotics with high stress levels to see if probiotics decreases stress levels.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Participants were required to
- Attend a visit to the nutrition clinic at Umm AL-Qura University to assess for eligibility.
- Eligible participants were asked to sign a consent form and anthropometrics, stress, bowel habits, food records and knowledge on probiotics were collected
- Participants were randomized based on lottery based method to an interventional or control group
- Intervention group received 30 capsules of probiotics (Lactobacillus rhamnosus GG, 6x10^9 cpu) to be taken once daily
- After 30 days, all participants had to attend a second visit at the nutrition clinic at Umm Al-Qura University to assess stress levels, bowel habits and receive their incentives (discount voucher of restaurants).
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Mecca, Saudi Arabia, 21955
- Umm Al-Qura University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Students at Umm Al-Qura University
- Age ≥ 18 years
- Healthy individuals
- Both genders
- Saudi nationality
Exclusion Criteria:
- Diagnosed with chronic illness or/and psychiatric condition
- Consumption of medications or supplements in the previous 3 months
- Pregnant and breastfeeding
- Smoker
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Experimental: cases
Consumed one probiotic for 30 days everyday with or without food.
Dicoflor 60 probiotic supplements were provided that contained Lactobacillus rhamnosus GG (ATCC 53103) that contained 6x10^9 colony forming units (cpu)) per capsule.
|
Already mentioned in arm/group descriptions
Other Names:
|
|
No Intervention: Controls
Had high stress levels but did not consume probiotics
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Stress
Time Frame: Post intervention at 30 days
|
Perceived stress scale (PSS) was used in both English and Arabic versionsndividual scores on the PSS can range from 0 to 40 with higher scores indicating higher perceived stress. Scores ranging from 0-13 would be considered low stress. Scores ranging from 14-26 would be considered moderate stress. Scores ranging from 27-40 would be considered high perceived stress. |
Post intervention at 30 days
|
|
Bowel function
Time Frame: Post intervention at 30 days
|
The questionnaire was developed to collect, comorbid illnesses, a prescription list, and specific questions related to bowel habits including fluid intake, usual diet, fecal matter consistency, frequency of defecation, and straining.
The questionnaire also contained questions about laxative usage, previous surgeries, and lifestyle.
The questionnaire was translated by an authorised translator and was based on a previous study.
|
Post intervention at 30 days
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Essra Noorwali, PhD, Umm Al-Qura University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- HAPO-02-K-012-2023-01-1414
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
The following may be shared:
Study Protocol Statistical Analysis Plan (SAP) Informed Consent Form (ICF) Clinical Study Report (CSR) Analytic Code
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Constipation
-
Hamilton Health Sciences CorporationNot yet recruitingConstipation | Constipation - Functional | Constipation AggravatedCanada
-
Peking Union Medical College HospitalInstitute of Process Engineering, Chinese Academy of SciencesNot yet recruitingChronic Constipation | Constipation - Functional | Fecal Microbiota TransplantationChina
-
Singapore Institute of TechnologyNot yet recruitingConstipation | Diet Modification | Constipation-predominant Irritable Bowel Syndrome | Diet Therapy | Constipation - Functional | Constipation Chronic Idiopathic | Constipation, Signs and Symptoms, Digestive | Dietary Fiber | Dietary Fibers | Constipation Predominant Irritable Bowel Syndrome | Dietary and... and other conditionsSingapore
-
usMIMA S.L.CompletedConstipation | Constipation Chronic Idiopathic | Constipation; NeurogenicSpain, United Kingdom
-
Selin KoşanActive, not recruitingChronic Constipation | Functional Constipation | Pelvic Floor | Biofeedback | Diaphragmatic BreathingTurkey (Türkiye)
-
Institute of Medical Sciences and SUM HospitalNot yet recruitingFunctional Constipation | Constipation - Functional | Constipation Chronic Idiopathic | Fecal Impaction | Pediatric Functional ConstipationIndia
-
Peking Union Medical College HospitalRecruitingChronic Constipation | Constipation - Functional | Fecal Microbiota Transplantation (FMT)China
-
Hong Kong Metropolitan UniversityNot yet recruitingConstipation | Constipation Drug Induced | Psychiatric Drug Induced ConstipationHong Kong
-
SK Life Science, Inc.CompletedChronic Constipation | Functional ConstipationUnited States
-
Hong Kong Metropolitan UniversityHospital Authority, Hong KongRecruitingConstipation | Constipation Drug Induced | Psychiatric Drug Induced ConstipationHong Kong
Clinical Trials on Probiotics (Lactobacillus rhamnosus GG (ATCC 53103)
-
San Giovanni Addolorata HospitalOnlus S. AndreaCompletedUlcerative Colitis Chronic Moderate | Ulcerative Colitis Chronic MildItaly
-
Istanbul UniversityCompletedDiabetes Mellitus, Type 2
-
Massachusetts General HospitalCompletedHealthy | ElderlyUnited States
-
Massachusetts General HospitalCompletedHealthy | ElderlyUnited States
-
Medical University of WarsawAdamed Pharma S.A.Not yet recruitingAntibiotic-associated DiarrheaPoland
-
Johann Wolfgang Goethe University HospitalCompleted
-
VA Eastern Colorado Health Care SystemUniversity of Colorado, Denver; University of Colorado, BoulderCompleted
-
Massachusetts General HospitalCompleted
-
Medical University of LodzCompletedHealthy | Anxiety | Stress-related Problem
-
Washington University School of MedicineNorthwestern University; Wayne State University; Columbia University; Brown University and other collaboratorsCompletedGastroenteritisUnited States